There is a significant risk of hypoglycaemia with intensification of insulin therapy, especially during
the first trimester, and glycaemic targets should be individualised. Severe hypoglycaemia, affecting up
to 40% of women, causes substantial morbidity (seizures, fractures and road-traffic accidents), and it is
the leading cause of death in type 1 diabetic pregnancy [25].